Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zhejiang Dragon Technology Co., Ltd. (603004.SS)
Hangzhou, SH, CN
Zhejiang Dragon Technology Co., Ltd. engages in the research and development, production, and sale of fine chemical products in China. The company provides cosmetics raw materials, special engineering materials, and other functional chemicals. The company was founded in 1989 and is headquartered in Hangzhou, China. Zhejiang Dragon Technology Co., Ltd. operates as a subsidiary of Zhejiang Dinglong New Materials Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.47% | -11.71% | -8.73% | -26.24% | -19.11% | -19.39% | -12.45% | +12.62% | +12.62% | +12.62% | +12.62% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals: +4.0%-0.4% Q1'26: +21.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-8.7% Q1'26: -20.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+23.3% Q1'26: +10.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+20.8% ★ Q1'26: +20.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+12.0% ★ Q1'26: +13.2% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.6% ★ Q1'26: -1.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.44× ★ Q1'26: 0.62× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
700.19M
est: 682.00M (+2.7%)
|
697.45M
est: 954.00M (-26.9%)
|
1.11B
1.11B – 1.11B
+16.1% YoY
|
1.30B
1.30B – 1.30B
+17.4% YoY
|
| EBITDA |
234.69M
est: 266.90M (-12.1%)
|
197.02M
est: 373.35M (-47.2%)
|
433.62M
433.62M – 433.62M
+16.1% YoY
|
509.15M
509.15M – 509.15M
+17.4% YoY
|
| EBIT |
197.04M
est: 190.69M (+3.3%)
|
145.11M
est: 266.74M (-45.6%)
|
309.80M
309.80M – 309.80M
+16.1% YoY
|
363.76M
363.76M – 363.76M
+17.4% YoY
|
| Net Income |
163.43M
est: 160.15M (+2.0%)
|
149.18M
est: 183.71M (-18.8%)
|
209.61M
209.61M – 209.61M
+14.1% YoY
|
242.59M
242.59M – 242.59M
+15.7% YoY
|
| SGA |
57.13M
est: 52.73M (+8.3%)
|
53.11M
est: 73.76M (-28.0%)
|
85.67M
85.67M – 85.67M
+16.1% YoY
|
100.59M
100.59M – 100.59M
+17.4% YoY
|
| EPS |
0.69
est: 0.68 (+1.5%)
|
0.63
est: 0.78 (-19.2%)
|
0.89
0.89 – 0.89
+14.1% YoY
|
1.03
1.03 – 1.03
+15.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chen Liu | Director & Deputy GM | — | male |
| Hanyu Zhou | Secretary & Director | — | female |
| Jiong Zhu | Deputy General Manager | — | male |
| Lijun Li | Financial Director | — | female |
| Qi Yun Jin | Accounting Supervisor | — | — |
| Yuanxiao Shi | MD & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603004.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
